Preparation method of temperature / pH response type hydrogel PDM and IPN and application of temperature / pH response type hydrogel PDM and IPN in drug release
By preparing temperature/pH responsive hydrogels PDM and IPN, combined with 5-Fu, the controlled release and biocompatibility of traditional hydrogels in drug transport is solved, and multiple responsiveness and high drug loading capacity are achieved. , suitable for oral colon targeted drug delivery.
Patent Information
- Application Number
- CN202411161336.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-29
AI Technical Summary
Traditional hydrogels have disadvantages in drug transport and administration, poor biocompatibility, and insufficient response ability to multiple stimuli, which limits their use in clinical applications.
Using the preparation method of temperature/pH responsive hydrogel PDM and IPN, hydrogels with enhanced mechanical properties and multiple responsiveness were prepared by the interpenetrating network method of DEA, MA and SA, and combined with 5-fluorouracil (5- Fu) for drug release application.
The preparation of temperature and pH sensitivity and ion-responsive hydrogels has been achieved, which has improved the controlled release ability and biocompatibility of drugs, significantly improved the drug loading and encapsulation rate, and is suitable for oral colon targeted drug delivery. .
Smart Images

Figure CN119039509A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of chemical drug synthesis, and in particular to a temperature / pH responsive hydrogel PDM, an IPN preparation method and an application thereof in drug release. Background Art
[0002] Oral chemotherapy drugs have the disadvantages of high toxicity, low utilization rate and easy to be affected by food, which limits their clinical application. Traditional hydrogels have the functions of transportation and drug delivery, but lack the controlled release of drugs. In addition, traditional hydrogels have the disadvantages of poor biocompatibility. Smart hydrogels can respond to stimuli such as temperature, pH, reactive oxygen species (ROS), glutathione, etc. of normal tissues and diseased tissues in organisms, and have received extensive attention and research in the biomedical field. Compared with single stimulus response systems, dual or multiple stimulus response systems can be more accurately targeted, and each stimulus can be fine-tuned independently to meet the controlled release of drugs. Therefore, the development of smart hydrogels with good biocompatibility and multiple responses is of great practical significance.
[0003] Sodium alginate (SA) is a natural linear polysaccharide. Its repeating unit structure is a block copolymer connected by α-L-mannuronic acid (M) and β-D-guluronic acid (G) 1,4. The molecular structure of SA contains a large number of hydrophilic groups such as hydroxyl and carboxyl groups, and has the advantages of low toxicity and good biocompatibility. As an important biomedical material, it has aroused great interest among researchers. The most common method is to use divalent cations to prepare SA hydrogels by physical cross-linking through chelation. The SA molecular structure contains a large number of -COO-. When divalent cations are added to the SA aqueous solution, the G unit forms an "egg box" structure with the divalent cations to form a hydrogel. Maleamidic acid (MA), as a derivative of maleic acid, contains unsaturated double bonds, hydrophilic carboxyl groups and amide groups in its molecular structure and has a certain pH sensitivity. After hydrolysis, the negatively charged carboxyl groups of maleamic acid and its derivatives are converted into positively charged amine groups. The amide bonds can be hydrolyzed under physiologically available weak acid conditions. Due to their unique weak acid sensitivity and charge conversion properties, they have been widely used in drug carriers. DEA, MA and SA were combined by the interpenetrating network method to prepare a temperature / pH sensitive hydrogel with enhanced mechanical properties. Summary of the invention
[0004] The invention aims to prepare a temperature / pH responsive hydrogel PDM, IPN, and provide the application of the hydrogel in drug release.
[0005] The present invention adopts the following technical scheme: a method for preparing a temperature / pH responsive hydrogel PDM, wherein a unit of the gel is prepared in proportion, comprising the following steps:
[0006] First, weigh 1.65g of DEA, weigh MA and MBA respectively according to the proportion, and then dissolve them in 5mL of deionized water. After being evenly dispersed by an ultrasonic cleaner, place it in an ice bath, and then slowly add APS / TEMED composite initiator. After mixing evenly, quickly transfer it to a vacuum needle tube and fully react in a water bath at 35°C for 12h. After the polymerization reaction is completed, the gel is slowly pushed out from one end of the piston, and then all are cut into cylindrical gel blocks with a thickness of 3mm. The gel blocks are placed in deionized water and soaked for 72h. The water is changed every 8h to remove unreacted monomers. Finally, the gel is freeze-dried for 48h.
[0007] Furthermore, when the molar ratio of DEA to MA is 25:1, the maximum porosity of PDM is 62% and the maximum swelling rate is 14.3 g·g -1 , the compressive strength is 28.81kPa.
[0008] Furthermore, IPN was prepared based on PDM hydrogel using a two-step method, firstly through free radical polymerization and then with Ca 2 +Ion crosslinking, the specific preparation process is as follows: first weigh a certain amount of SA and dissolve it in 4mL deionized water, then weigh 1.65g of DEA and a certain amount of MA and MBA and dissolve them in 4mL deionized water, use an ultrasonic cleaner to disperse them evenly, place them in an ice bath, then slowly add APS / TEMED composite initiator, mix them evenly and transfer them to a vacuum needle tube, place them in a 35°C water bath to react for 12h; after the polymerization reaction is completed, the gel is slowly pushed out by a piston at one end, and then all are cut into cylindrical gel blocks with a thickness of 3mm, and then placed in a 2% CaCl2 solution to soak for 8h, and then transferred to deionized water to soak for 72h, and the water is changed every 8h to remove unreacted monomers and excess Ca 2 +, finally the gel is freeze-dried for later use.
[0009] Furthermore, when the SA content is 75 mg, the minimum porosity of the IPN is 37.42% and the minimum swelling rate is 6.2 g·g -1 , the compressive strength is 109.84kPa.
[0010] Application of temperature / pH responsive hydrogel PDM and IPN combined with 5-fluorouracil in drug release.
[0011] Beneficial effects of the present invention: The present invention prepares a temperature / pH responsive hydrogel PDM, IPN, which has certain temperature and pH sensitivity and ion responsiveness, and combined with 5-fluorouracil, 5-Fu@PDAE5 has good drug loading and release capabilities. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 Schematic diagram of the preparation of SA / P(DEA-MA) hydrogel;
[0013] Figure 2 Infrared spectra of DEA, MA, SA, PDM, and IPN;
[0014] Figure 3 SEM images of PDM1 to PDM3;
[0015] Figure 4 SEM images of IPN1 to IPN3;
[0016] Figure 5 Porosity diagrams of PDM1 to PDM3 and IPN1 to IPN3;
[0017] Figure 6 Stress-strain curves of PDM1-PDM3 and IPN1-IPN3 hydrogels;
[0018] Figure 7 Swelling kinetics of PDM1~PDM3 and IPN1~IPN3 in deionized water;
[0019] Figure 8 Changes in swelling ratio of PDM1~PDM3 and IPN1~IPN3 with temperature;
[0020] Fig. 9 The bar graph of the swelling rate changes of PDM1~PDM3 and IPN1~IPN3 under different pH conditions;
[0021] Fig.10 The drug loading capacity test diagram of PDM1~PDM3, IPN1~IPN3 for 5-Fu, (a) - drug loading capacity; (b) - maximum encapsulation efficiency;
[0022] Fig.11 In vitro release curve of 5-Fu@IPN1 hydrogel. DETAILED DESCRIPTION
[0023] Embodiment 1:
[0024] Three temperature / pH responsive hydrogels with different monomer ratios were synthesized by aqueous solution free radical polymerization using DEA and MA, which are replaced by the abbreviation PDM below. The specific preparation process is as follows: First, weigh 1.65g of DEA, weigh MA and MBA according to the proportions in the table, and then dissolve them in 5mL of deionized water. After being evenly dispersed using an ultrasonic cleaner, place it in an ice bath, and then slowly add APS / TEMED composite initiator. After mixing evenly, quickly transfer it to a vacuum needle tube and fully react in a water bath at 35°C for 12 hours. After the polymerization reaction is completed, the gel is slowly pushed out by the piston at one end, and then all are cut into cylindrical gel blocks with a thickness of 3mm. The gel blocks are placed in deionized water and soaked for 72 hours, and the water is changed every 8 hours to remove unreacted monomers, and then the gel is freeze-dried for 48 hours.
[0025] SA / P(DEA-MA) interpenetrating network hydrogel was prepared based on PDM hydrogel by a two-step method. First, it was initially cross-linked by free radical polymerization and then reacted with Ca 2 +Ionic crosslinking is carried out, and the abbreviation IPN is used instead. The specific preparation process is as follows: first, weigh a certain amount of SA and dissolve it in 4 mL of deionized water, then weigh 1.65 g of DEA and a certain amount of MA and MBA and dissolve them in 4 mL of deionized water. After being evenly dispersed using an ultrasonic cleaner, place it in an ice bath, and then slowly add the APS / TEMED composite initiator, mix evenly and transfer it to a vacuum needle tube, and place it in a 35°C water bath for 12 hours. After the polymerization reaction is completed, the gel is slowly pushed out by the piston at one end, and then all are cut into cylindrical gel blocks with a thickness of 3 mm, and then placed in a 2% CaCl2 solution to soak for 8 hours, and then transferred to deionized water to soak for 72 hours. The water is changed every 8 hours to remove unreacted monomers and excess Ca 2 +, finally the gel is freeze-dried for later use.
[0026] The synthesis conditions of PDM1~PDM3 and IPN1~IPN3 are shown in Table 1.
[0027] Table 1 Feeding amount of each component of PDM and IPN hydrogel
[0028]
[0029] FT-IR analysis of PDM and IPN
[0030] The potassium bromide tablet method was used to perform infrared spectroscopy on the reaction monomers, PDM and IPN. The results are as follows: Figure 2 shown.
[0031] In the infrared spectrum of DEA, we can see that 2975cm -1 、1363cm -1It is the asymmetric stretching vibration absorption peak and bending absorption vibration peak of CH in -CH3, 2876cm -1 、1448cm -1 It is the symmetrical stretching vibration peak and bending absorption vibration peak of CH in -CH2, 1649cm -1 The peak at 1262 cm is the overlapping peak of the stretching vibration peak of C=O and C=C, which are unique to tertiary amides. -1 It is the stretching vibration peak of tertiary amide CN. In the infrared spectrum of maleamic acid, we can see that 3375cm -1 、3190cm -1 It is the antisymmetric and symmetric stretching vibration peak of -NH2, 1715cm -1 is the stretching vibration peak of -COOH, 1615cm -1 The peaks are -C=C- and amide I bands overlap. In the spectrum of SA, 3340 cm -1 It is the stretching vibration peak of hydroxyl (-OH), 2884cm -1 The stretching vibration peak of -CH is 1593cm -1 、1340cm -1 -COO - Symmetric and antisymmetric stretching vibration peaks, 1055 cm -1 It is the stretching vibration peak of COC. From the infrared spectrum of PDM, we can see that 2975, 1610, 1444 and 1271 cm -1 These may be the characteristic peaks of DEA, 3263cm -1 Possibly characteristic peaks of MA, 3419 and 1055 cm -1 It is the characteristic peak of SA. From the infrared spectrum of IPN, compared with the spectra of SA and PDM, the -COO - The symmetric and antisymmetric stretching vibration absorption peaks of the IPN shifted to the left to a longer wavelength, indicating the presence of Ca 2 + and -COO - The binding effect between ions.
[0032] SEM analysis of PDM and IPN
[0033] The six types of hydrogels PDM1~PDM3, IPN1~IPN3 after swelling equilibrium were freeze-dried and subjected to SEM test after gold spraying. Figure 3 , 4 .
[0034] 1) Effect of MA ratio on PDM surface morphology
[0035] Depend on Figure 3It can be seen that the pores of PDM are clear and interconnected, arranged in a honeycomb shape. A large number of holes are conducive to the entry of water molecules into the gel, and also provide a basis for the loading and release of drug molecules. In addition, the pore size of the hydrogel gradually increases with the increase of the MA content in the system. The carboxyl and amide groups in the MA structure are both hydrophilic groups. The proportion of hydrophilic groups in the gel system is greatly increased, making it easier for the gel to combine with water molecules, making the gel pore size larger.
[0036] 2) Effect of SA ratio on IPN surface morphology
[0037] Figure 4 The SEM images of IPN1 to IPN3 with increasing SA content show that after adding SA, the gel has a relatively clear and uniform pore structure when the content is low. As the content increases, the gel pores gradually become smaller and of different sizes, and even disappear. This phenomenon may be due to the fact that after adding SA, the polymer network undergoes ion crosslinking, making the internal structure more compact; on the other hand, it may be due to the strong hydrogen bonding between SA and the polymer chain, which increases the crosslinking density of the system.
[0038] Porosity study of PDM and IPN
[0039] The porosity of PDM1~PDM3 and IPN1~IPN3 was investigated by ethanol replacement method. The results are as follows: Figure 5 shown.
[0040] As can be seen from the figure, the porosity of PDM1~PDM3 and IPN1~IPN3 are 40.08%, 48.62%, 62.00%, 53.26%, 47.26% and 37.42% respectively. The porosity of PDM1~PDM3 increases with the increase of the proportion of maleamic acid in the gel system. A large number of carboxyl groups increase the hydrophilicity of the gel. From the SEM image, it can be seen that the gel pore size gradually increases, and water molecules can more easily enter and exit the gel, which increases the gel porosity. The porosity of IPN1~IP N3 decreases with the increase of sodium alginate content in the system. The increase of sodium alginate content increases the degree of ionic crosslinking, the crosslinking density of the system increases, and the gel network becomes tighter, which reduces the pore size, increases the pore density, and reduces the porosity, which is consistent with the results of the SEM image. The porosity of the gel is proportional to the pore size of the gel and inversely proportional to the mechanical strength of the gel.
[0041] Due to the particularity of the drug release environment of hydrogels in the body, the hydrogels are required to have certain mechanical properties, so the mechanical properties of the hydrogels were tested.
[0042] Compression test
[0043] In this experiment, an electronic universal tensile testing machine was used to test the mechanical properties of the swelling equilibrium gel. The stress-strain curves of PDM1~PDM3 and IPN1~IPN3 hydrogels are shown in Figure 6 , the hydrogel compressive strength test data is shown in Table 2.
[0044] Depend on Figure 6 As can be seen from Table 2, the compressive strength of hydrogels PDM1 to PDM3 decreases significantly in turn. When DEA:MA is 125:1, the compressive strength is the highest, 92.19 kPa, and when DEA:MA=25:1, the compressive strength is the lowest, 28.81 kPa. This is because the proportion of MA in the gel system increases, which increases the gel pore size and greatly increases the water molecule content, which greatly weakens the compressive strength. The compressive strength of IPN1 to IPN3 hydrogels gradually increases, and the compressive strength of IPN3 reaches 109.84 kPa, which is 381.3% higher than that of PDM3 hydrogel without SA. This is because after SA is added to the system, after ionic crosslinking, the crosslinking density increases, the pore size decreases, and the water absorption rate decreases, resulting in an increase in the compressive strength of the gel. Combined with the SEM image of the gel, it can be seen that the mechanical strength of the gel is inversely proportional to the pore size of the gel.
[0045] Table 2 Compressive strength test data of PDM and IPN hydrogels
[0046]
[0047] Study on the swelling properties of PDM and IPN
[0048] 1) Study on the swelling kinetics of PDM and IPN
[0049] When used as a drug carrier, the swelling capacity of the hydrogel affects its ability to encapsulate and release drugs. A freeze-dried sample of known mass was placed in deionized water at 25°C, and its mass was measured at regular intervals to obtain the swelling kinetics of PDM1-PDM3 and IPN1-IPN3. The results are as follows: Figure 7 shown.
[0050] As can be seen from the figure, the swelling rates of PDM1-PDM3 and IPN1-IPN3 hydrogels were fast in the first 2 h, and then slowed down from 2 h to 7 h. After 7 h, the swelling rates of the gels reached equilibrium. The equilibrium swelling rates of the six gels were 7.4 g·g -1 , 10.1 g·g -1 , 14.3 g·g -1 , 12.5g·g -1 , 8.6 g·g -1 and 6.2 g·g -1 .
[0051] The results show that the swelling rates of PDM1 to PDM3 hydrogels increase successively. As the proportion of maleamic acid increases, the proportion of carboxyl groups in the gel system also increases accordingly. The carboxyl groups are ionized in deionized water, and a large number of like-charge repulsions make the gel network loose, and it is easy for water molecules to enter and exit the gel network, so the hydrogen bonding between carboxyl groups and water molecules is enhanced. In addition, it can be seen from the SEM image and gel porosity that as the proportion of maleamic acid increases, the gel pore size increases successively, the porosity increases, and therefore its swelling capacity gradually increases.
[0052] The swelling rate of IPN1~IPN3 hydrogels decreases with the increase of sodium alginate content. This is because the increase in the proportion of sodium alginate leads to an increase in the degree of ionic crosslinking, and then an increase in the crosslinking density of the gel. According to the SEM image and porosity image, it can be seen that the pore size of the gel gradually decreases and the porosity decreases, which leads to a decrease in the swelling ability of the gel.
[0053] 2) Study on temperature sensitivity of PDM and IPN
[0054] The swelling results of PDM1~PDM3 and IPN1~IPN3 in deionized water at different temperatures are shown in Figure 2. Figure 8 As shown in Figure 1, DEA is one of the most widely used temperature-sensitive monomers. It has hydrophobic groups (ethyl groups) and hydrophilic groups (amide groups) in its molecular structure. The polymer containing DEA has a minimum critical solution temperature (LCST). At different temperatures, the internal structure of the gel changes, which in turn affects the external morphology of the gel, making it exhibit a temperature-sensitive property.
[0055] From the figure, we can see that the equilibrium swelling rate of the six samples at different temperatures has the same trend. As the temperature increases, the equilibrium swelling rate decreases. It can be seen that the addition of sodium alginate to the system does not affect the temperature sensitivity of the gel. At lower temperatures, the polymer structure is more stretched, the hydrophilic group plays a dominant role, the channel for water molecules to enter and exit the gel is larger, and the hydrogen bonding between the gel and external water molecules is stronger, resulting in a larger swelling rate of the gel; as the temperature rises, when the temperature is above the LCST, the gel structure may collapse or shrink. At this time, the hydrophobic group dominates, and it is difficult for water molecules to enter the gel. At the same time, the hydrogen bonding inside the gel is strong, resulting in a decrease in the swelling rate of the gel.
[0056] 3) Study on pH sensitivity of PDM and IPN
[0057] The swelling rates of PDM1-PDM3 and IPN1-IPN3 in different pH environments (1.2, 7.4) were measured. Fig. 9As shown. As can be seen from the figure, the six samples have obvious differences at different pH values. The swelling rate at pH = 7.4 is higher than that at pH = 1.2, and they all have very obvious pH sensitivity. The higher the MA content, the more obvious the difference in swelling rate of PDM1-PDM3 hydrogels at different pH values. This is because in a strong acid environment, the hydrogen bonding effect between molecular chains is larger, and the carboxyl groups in MA will be protonated, resulting in a relatively tight gel structure and a reduced swelling rate; while in a neutral environment, the carboxyl groups of MA are deprotonated, causing the gel to carry a large amount of negative charge. The electrostatic repulsion makes the structure of the gel loose, and water molecules can easily enter and exit the gel, resulting in an increase in the swelling rate.
[0058] In addition, it can be seen that the addition of SA did not affect the pH responsiveness of IPN1 to IPN3. It was just that the addition of SA made the gel structure tight after ionic cross-linking, resulting in a decrease in the swelling rate.
[0059] Drug loading performance test of PDM and IPN
[0060] A certain amount of freeze-dried PDM1-PDM3 and IPN1-IPN3 was placed in 10 mL of 1 mg mL -1 The 5-Fu aqueous solution was placed in a water bath shaker at 25°C and 150 rpm. After 24 hours, the gel was taken out and freeze-dried to obtain the drug-loaded dry gel.
[0061] The drug loading and encapsulation efficiency of PDM1~PDM3 and IPN1~IPN3 for 5-Fu Fig.10 shown.
[0062] As can be seen from the figure, the encapsulation capacity of the six hydrogels for 5-Fu is in the same order as the swelling rate of the gel. <PDM2<PDM3、IPN1> IPN2>IPN3. The drug loading of PDM1~PDM3 and IPN1~IPN3 is 11.89 mg g -1 , 41.39mg·g -1 、61.55mg·g -1 , 53.80mg·g -1 、31.57mg·g -1 , 7.01mg·g -1 The encapsulation rates were 9.12%, 29.82%, 46.16%, 38.74%, 24.62% and 5.31% respectively. Considering the actual application environment of the gel, the gel is required to have not only a high drug loading and encapsulation rate, but also certain mechanical properties. Therefore, IPN1 was selected as the next drug release research object. Drug release performance test of PDM and IPN
[0063] To test the drug release performance of 5-Fu@IPN1, PBS buffer solutions with different pH values (1.2, 7.4) were prepared with Na2HPO4 and KH2PO4, and the dry gel of 5-Fu@IPN1 with known drug loading and 3 mL of PBS buffer solutions with different pH values were placed in a dialysis bag.
[0064] The two main factors affecting the release of drugs from the gel are the swelling capacity of the gel and the interaction between the drug and the internal structure of the gel. The drug release of 5-Fu@IPN1 gel at 37°C and different pH values was investigated. Fig.11 As shown in the figure, the drug release rate of the gel in both environments is initially fast, and gradually slows down until equilibrium is reached. In the initial stage of drug release, there is a large gap between the drug concentration in the gel and the drug concentration in the dilution medium, so the drug release rate is fast. As the drug is released, the concentration gradient between the two gradually decreases, causing the drug release rate to gradually slow down and eventually reach equilibrium.
[0065] In an environment with a pH value of 1.2, the release rate of 5-Fu is slow and the release amount is low, and the cumulative release rate of the drug is 21.72%. When the pH value is 7.4, the release rate of 5-Fu is fast and the cumulative release amount is high, and the cumulative release rate of the drug is 53.10%. The cumulative release rate of the drug at a pH value of 7.4 is higher than that at a pH value of 1.2. This is because the swelling rate of the gel in an acidic environment is small, and there is a strong hydrogen bond between the gel and 5-Fu, which makes it difficult for 5-Fu to be released from the gel. In addition, since 5-Fu is a negative ion drug, at a pH value of 7.4, a large number of carboxyl groups of maleamic acid and sodium alginate in the gel are deionized. At this time, both the gel and the drug are negatively charged, and the repulsion of the same charge accelerates the release of 5-Fu. It can be seen that IPN1 gel has a good pH response, and the cumulative release rate of 14h can reach more than 50%, which provides a certain application value for use as an oral colon-targeted drug delivery carrier.
[0066] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. Preparation method of temperature / pH responsive hydrogel PDM, It is characterized in that The preparation of one unit of the gel in proportion comprises the following steps: First, weigh 1.65 g of DEA, weigh MA and MBA respectively according to the proportion, and then dissolve them in 5 mL of deionized water. After being evenly dispersed using an ultrasonic cleaner, place it in an ice bath, and then slowly add the APS / TEMED composite initiator. After mixing evenly, quickly transfer it to a vacuum syringe and fully react in a water bath at 35 °C for 12 h. After the polymerization reaction is completed, the gel is slowly pushed out by the piston at one end, and then all of them are cut into cylindrical gel blocks with a thickness of 3 mm. The gel blocks are soaked in deionized water for 72 h, and the water is changed every 8 h to remove unreacted monomers. Finally, the gel is freeze-dried for 48 h.
2. The method for preparing the temperature / pH responsive hydrogel PDM according to claim 1, It is characterized in that When the molar ratio of DEA to MA is 25:1, the maximum porosity of PDM is 62% and the maximum swelling rate is 14.3 g·g −1 , the compressive strength is 28.81 kPa.
3. Preparation method of temperature / pH responsive hydrogel IPN, It is characterized in that IPN was prepared based on PDM hydrogel using a two-step process: first, it was initially cross-linked by free radical polymerization and then 2+ The specific preparation process is as follows: first, a certain amount of SA is weighed and dissolved in 4 mL of deionized water, and then 1.65 g of DEA and a certain amount of MA and MBA are weighed and dissolved in 4 mL of deionized water. After being evenly dispersed by an ultrasonic cleaner, it is placed in an ice bath, and then the APS / TEMED composite initiator is slowly added. After being mixed evenly, it is transferred to a vacuum needle tube and placed in a 35 °C water bath for water bath reaction for 12 h. After the polymerization reaction is completed, the gel is slowly pushed out by a piston at one end, and then all are cut into cylindrical gel blocks with a thickness of 3 mm, and then placed in 2% CaCl 2 The samples were immersed in the solution for 8 h, and then transferred to deionized water for 72 h, with the water changed every 8 h to remove unreacted monomers and excess Ca 2+ Finally, the gel is freeze-dried for later use.
4. The method for preparing the temperature / pH responsive hydrogel IPN according to claim 3, It is characterized in that When the SA content is 75 mg, the minimum porosity of IPN is 37.42% and the minimum swelling rate is 6.2 g·g −1 , the compressive strength is 109.84 kPa.
5. Application of temperature / pH responsive hydrogel PDM and IPN combined with 5-fluorouracil in drug release.
